Cynosure Launches TempSure Surgical RF Technology in North America

Photo courtesy of Cynosure

The FDA has approved the TempSure Surgical RF technology in North America. The device, created by Cynosure, which is a division of Hologic, helps medical-spa professionals perform both surgical and non-surgical treatments. TempSure Surgical RF is used for plastic surgery, dermatology, gynecology, and ophthalmology. 

The RF technology uses a 300-watt and 4-MHz radiofrequency system, which allows for shorter recovery periods. “We’re continually innovating to ensure our customers set themselves apart with effective and diverse treatment offerings, and this enhanced platform is a game changer across specialties,” says Kevin Thornal, Hologic’s division president, Cynosure.

“The cutting-edge technology of the TempSure platform will now allow doctors to transition seamlessly from invasive to non-invasive treatments on one device.” TempSure Surgical RF is an enhancement to TempSure’s radio frequency program, which runs with the overarching TempSure Envi device.


RELATED STORIES

Alma Lasers Debuts BeautFill Laser-Based System

Slow Breast Sagging With These Simple Tips

One Plastic Surgery Procedure Stays Popular Despite Industry Changes

Suggested Articles

The device allows medical aesthetics clinicians to treat a wider range of skin conditions.

He was most recently managing director of the SHIELD innovation center of Nestlé Skin Health/Galderma in New York City.

The price adjustments are a part of the brand’s #ColourItForwardCampaign.